← Back
F

$ Value

$9K

Shares

483

Price

$19

Filed

Nov 10

Insider

Name

Merrell Brendan W.

Title

CHIEF OPERATING OFFICER

CIK

0002090383

Roles

Officer

Transaction Details

Transaction Date

2025-10-03

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

27,208

Footnotes

Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date. | These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. | The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.

Filing Info

Accession No.

0001628280-25-050825

Form Type

4

Issuer CIK

0001448431

Merrell Brendan W.'s History

Date Ticker Type Value
2025-12-19 OPRX F $4K
2025-12-11 OPRX F $10K
2025-10-03 OPRX F $9K
2025-08-21 OPRX A $0
2025-08-21 OPRX A $0

Other Insiders at OPRX (90d)

No other insider activity at this issuer in the last 90 days.